Results 81 to 90 of about 41,456 (235)
MUCOLYTICS IN BRONCHOPULMONARY DYSPLASIA THERAPY
Педиатрическая фармакология, 2012 Mucolytic drugs, particularly, direct action mucolytics with acetylcysteine derivatives among them, are included in the complex therapy of the bronchopulmonary dysplasia exacerbations.
I. V. Davydova +3 more
doaj +1 more source
Lung interstitial cells during alveolarization [PDF]
Korean Journal of Pediatrics, 2010 Recent progress in neonatal medicine has enabled survival of many extremely low-birth-weight infants. Prenatal steroids, surfactants, and non-invasive ventilation have helped reduce the incidence of the classical form of bronchopulmonary dysplasia ...
Chang Won Choi
doaj +1 more source
Trends in survival among extremely-low-birth-weight infants (less than 1000 g)without significant bronchopulmonary dysplasia [PDF]
, 2015 Objective The aim of this study was to analyze the evolution from 1997 to 2009 of survival without significant (moderate and severe) bronchopulmonary dysplasia (SWsBPD) in extremely-low-birth-weight (ELBW) infants and to determine the influence of ...
Botet Mussons, Francisco +5 more
core +2 more sources
Acta Paediatrica, EarlyView.ABSTRACT Aim Caffeine is the mainstay of treatment for apnea of prematurity, yet the optimal strategy and timing for discontinuation remain undefined. Marked inter‐centre variation in the practise of discharging preterm infants home on caffeine therapy has been reported.
Martin Kuntz +5 more
wiley +1 more source
The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs [PDF]
, 2001 Background Recent reports have raised concerns that postnatal steroids may cause neuro-developmental impairment in preterm infants. This systematic review was performed with the objective of determining whether glucocorticoid therapy, to prevent or treat
Keith J Barrington +27 more
core +2 more sources
Acta Paediatrica, EarlyView.ABSTRACT Aim Optimal treatment strategies for patent ductus arteriosus (PDA) and their impact on neurodevelopmental outcomes remain controversial. This study investigates the influence of PDA duration on neurodevelopment under a restrictive treatment approach.
Moses Kallenberger +8 more
wiley +1 more source
Osmolality of preterm formulas suplemented with monprotein energy supplements [PDF]
, 2007 Background: Addition of energy supplements to preterm formulas is an optional strategy to increase the energy intake in infants requiring fluid restriction, in conditions like bronchopulmonary dysplasia.
Dias, M. Pitta-Grós +4 more
core +1 more source
Long‐Term Societal Costs After Births Before 24 Weeks of Gestation in Sweden
Acta Paediatrica, EarlyView.ABSTRACT Aim Extremely preterm birth is associated with high morbidity and long‐term support needs. This study estimated long‐term medical and non‐medical costs throughout childhood among children born before 24 weeks of gestation in Sweden. Methods This nationwide register‐based study included 344 infants born before 24 weeks of gestation in Sweden ...
Chatarina Löfqvist +8 more
wiley +1 more source
Birth, EarlyView.*Adjusted for gestational age at delivery. aOR, adjusted odds ratio; CD, cesarean delivery; IRDS, infant respiratory distress syndrome; IVH, interventricular hemorrhage; OR, odds ratio; ROP, retinopathy of prematurity; VD, vaginal delivery. ABSTRACT Background Triplet pregnancies are increasingly leaning toward planned cesarean deliveries (CD), yet ...
Petra M. van Baar +5 more
wiley +1 more source